Jim Corbett Email & Phone Number

Boston, Ma, Us

Providing executive leadership for Emulate, a successful Life Science company, commercializing innovative Organs-on-Chips technology. Emulate creates living platforms that emulate the complexities of human biology to enable unprecedented insights into human biology and health. Our Human Emulation System sets a new standard for recreating true-to-life human biology and is now being used to advance product innovation, design, and safety across a range of applications, including drug development, agriculture, cosmetics, food, and chemical-based consumer products.

Shelton, Ct, Us

Responsible for division with 4,000 employees.• Formed new operating division through the combination of the Environmental Health, Life Sciences, OneSource and Informatics businesses.• Completely transformed leadership team by adding more than one-third of leadership team from the outside.• Reorganized commercial and business unit structure to better align and drive top-line growth, transforming a business with successive years of 0% top-line growth to 4% top-line growth in 2017 and 7% in 2018.• Consolidated R&D functions and standardized product development process across division, producing an unprecedented 14 new platforms, 200 new assays and more than $122 million in new product revenue.• Developed focused strategy to drive simplification of business model while expanding operating margins by 120 bps.• Expanded Life Science’s portfolio with the acquisition of Cisbio (France) and the Chromatography portfolio through the acquisition of Dani (Italy). • Expanded emerging markets footprint through acquisition of Shanghai Spectrum with expertise in elemental analysis and expanded analytical instruments manufacturing into China.• Closed single largest account in company’s history with a five-year OneSource deal valued at $150 million-plus.

Shelton, Ct, Us

Added responsibility to reorganize and combine Life Sciences, Informatics and OneSource teams to form Life Sciences Solutions business with 2,000 employees.• Realigned OneSource business to improve profitability while increasing organic growth. • Implemented new pricing structures, contract requirements and disciplined operating procedures. • Changed leadership and organizational structure of Informatics team to better align with commercial teams to drive top-line growth.• Consolidated discovery business under one leader and streamlined product development process to allow for more accelerated product growth.

Shelton, Ct, Us

Led three operating divisions – Diagnostics, Life Sciences and Medical Imaging; oversaw 5,000 employees. ■ Managed three division presidents on an operating basis while setting strategy to focus Human Health business.■ Divested Medical Imaging business, strengthening portfolio and increasing focus on desired end markets.

Shelton, Ct, Us

Extended responsibility to lead Life Sciences division in addition to Diagnostics team; oversaw 3,000 employees globally.• Managed three division presidents on an operating basis while setting strategy to focus Human Health business.• Divested Medical Imaging business for a purchase price of $276 million, strengthening portfolio and increasing focus on desired end markets.

Shelton, Ct, Us

Led global Diagnostics business with 2,000 employees.• Consistently drove top-line growth while expanding operating margins.• Expanded emerging market footprint with acquisition of Haoyuan Biotech, a Chinese blood screening company, advancing portfolio within Chinese market to become one of only five companies approved to do nucleic acid testing on country’s blood supply.• Built molecular capability with acquisition of Chemagen (Germany), a nucleic acid sample prep company; successfully integrated technology to allow for internal development of three distinct platforms, expanding position in viral load testing, genomics and NIPT.• Opened China service laboratory to expand offering to fast-growing China service laboratory market; worked with local authorities to acquire appropriate licenses, built facilities and recruited staff.

Shelton, Ct, Us

Managed North America operations encompassing 440 employees, five locations, two diagnostic testing service laboratories, two customer sales and support operations, and a cord blood stem cell preservation laboratory. Responsible for business development activities related to licensing, distribution and acquisitions that supported strategic plan. Responsible for customer service, quality and regulatory activities related to broad product portfolio with varying regulatory requirements.• Integrated four acquisitions over 36 months to form a cohesive organization focused on leveraging product portfolio through newly acquired distribution channels.• Developed strategic plan, including menu expansion in prenatal and neonatal service laboratories, expansion of stem cell offering and repositioning of company to end customers, including consumers, obstetrics professionals and laboratorians.• Oversaw software development team that provided unique software solutions for integrated genetic testing facilities.• Served as media spokesperson for all activity related to company and industry inquiries for genetic testing and stem cell sectors.

Managed a multifaceted biotechnology company with 225 employees. Oversaw an FDA-, AABB- and CLIA-approved processing facility of 50 employees operational 365 days per year. Managed development teams for preclinical and clinical cellular therapy development programs.• Developed a diverse healthcare, commercial organization that encompassed a strong consumer reach and a large professional ObGyn sales and marketing organization.• Constructed logistics network to transport umbilical cord blood from more than 3,000 hospitals in the U.S.• Development focus in the areas of hematopoietic transplants and stem cell expansion, isolation and production for use in myocardial infarction and for type 1 diabetes.• Grew revenue 24% and 21% year over year in 2006 and 2007 respectively. • Built out an ObGyn sales force from 12 to 50 and developed a consumer marketing and sales organization to drive a new and innovative healthcare product offering.• Presented at investor conferences and analyst meetings, representing company to financial markets, institutional investors and key shareholders.

Nashua, Nh, Us

• Developed and implemented strategic business plan managing worldwide commercial activity accountable for the consolidated P&L; exceeded sales and profit plan with year-over-year revenue growth of 91%, achieving $23 million in revenue.• Negotiated corporate licensing, development and distribution agreements with Siemens Medical, GE Healthcare, Hologic, Vital Images, TeraRecon, Viatronix, IMS and Confirma with the initial GE agreement contributing 30% of company revenue. • Achieved profitability in the second quarter post merger and continued to improve gross margins and operating income, reporting $0.1 EPS in Q3. • Implemented and negotiated merger of iCAD and CADx Systems, providing a liquidity event for CADx shareholders and positioning the company for future growth.• Represented company to public financial markets by presenting at annual investor conferences and to institutional investors. • Involved in sale of stock through a large private placement raising $8.4 million in capital.

Founder of CADx Systems, Inc., responsible for worldwide commercial activity of this medical software start-up. Corporate Officer, Board of Directors – CADx Systems, Inc. and Qualia Computing, Inc. Managed worldwide sales, marketing, technical support and business development staff.• Developed strategic business plan that founded CADx Systems, securing $30 million in financing, and engineered spin-off of CADx to become an independent company.• Established and managed distribution network covering 33 countries globally.• Negotiated development, licensing and distribution of OEM partnerships with industry leaders in the breast imaging arena – GE Healthcare, Hitachi Medical, Hologic, Fischer Imaging and SourceOne Healthcare.• Negotiated patent infringement settlement with main competitor and implemented new intellectual property strategy within the company.• Managed R&D during design, development and launch phase of the initial breast cancer product, Second Look™, working with industry luminaries to develop vision and strategy for product family.• Executed quality and regulatory strategies to receive FDA Premarket Approval for a Class III device along with international approval for the KFDA, JCMO and CE marking.• Selected and managed start-up of third party manufacturing, minimizing capital investment, and implemented inventory control systems, ensuring 100% product availability.

A corporate officer, responsible for developing and implementing a strategic business plan.

Abbott Park, Illinois, Us

Region Manager, Abbott Diagnostics, Boston, MA (1996 – 1998) Worldwide Marketing Manager, Abbott Diagnostics, North Chicago, IL (1994 – 1996)Business Unit Marketing Manager, Abbott Diagnostics, Chicago, IL (1993 – 1994) District Sales Manager, Abbott Diagnostics, Hartford, CT (1991 – 1993) U.S. Marketing Product Manager, Abbott Diagnostics, Chicago, IL (1989 – 1991) Account Executive, Sales, Abbott Diagnostics, New York, NY (1987 – 1989) Systems Specialist, Sales, Abbott Diagnostics, Boston, MA (1985 – 1987)